Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

v3.21.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS

 

The Company billed the remaining $2,500,000 milestone payment to CFF in October 2021 after submitting the final clinical study report. CFF's acceptance of this report will then trigger payment.